Search results - 37 results
Large-scale cross-sectional serological survey of Schmallenberg virus in Belgian cattle at the end of the first vector season.
cross-sectional studies Enzyme-Linked Immunosorbent Assay Female Orthobunyavirus Seasons Seroepidemiologic Studies Serologic Tests Abstract: A cross-sectional survey was conducted in the Belgian cattle population ...
Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules36549
of viral infections and cross protection, simultaneous targeting of multiple viral epitopes is a powerful strategy. Llama heavy chain antibody fragments (VHH) against the trimeric envelope proteins of ...
Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses.
immunization with naked- DNA. Furthermore, intranasal DNA vaccination with HA from a given H5N1 virus elicited full protection against the parental strain and partial cross-protection against a distinct highly ...
Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice36543
pathogen prevention & control production protection protein Pulmonary Research Research Support response Responses result results Role SB- IM secretion Spleen System Tuberculosis tumor Tumor Necrosis ...
Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests.
lpELISA titers showed an excellent repeatability, reproducibility and concordance with PPG for vaccine potency, assessments of cross-protection by VNT titers were more consistent with the PPG outcome. ...
Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
Source: Vaccine, Volume 27, Issue 45, p.6330-9 (2009) Keywords: Animals Antibodies, Viral Cross Protection Cross Reactions Immunity, Cellular Immunity, Humoral Influenza A Virus, H1N1 Subtype Influenza ...
Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology.
of foot-and-mouth disease (FMD) virus can be assessed in vivo or by serological r-value determination. Sera from animals involved in vaccine potency and cross-protection trials performed using the ...
Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Volume 18, Issue 1, p.321-30 (2009) Keywords: ADOLESCENT Adult Aged Aged, 80 and over Analysis of Variance Belgium Chi-Square Distribution cross-sectional studies Early Detection of Cancer Female Humans ...
Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the "Protection against Podal Generalisation" test.
and 73.7%, respectively. In four heterologous challenge PPG tests, the overall level of cross-protection induced by the A(24) Cruzeiro/Brazil/55 vaccine against A Argentina/2001 challenge was 26.6%, ...
Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3.
DNA vaccines encoding the 32,000 MW mycolyl-transferase Ag85A and the 40,000 MW phosphate-binding protein PstS-3 can elicit protective immune responses against experimental infection with Mycobacterium ...